Genentech Seeks Preemption Summary Judgment In Herceptin Vial MDL
(August 25, 2016, 1:12 PM EDT) -- TULSA, Okla. — Genentech Inc. on Aug. 23 moved for summary judgment in the Herceptin vial multidistrict litigation, arguing that plaintiff claims that vials were underfilled are preempted by federal law...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login